# Neoadjuvant Radiotherapy for High-risk UTUC

> **NCT06472752** · — · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Urothelial Carcinoma of the Renal Pelvis and Ureter

## Interventions

- **RADIATION:** Neoadjuvant radiotherapy
- **COMBINATION_PRODUCT:** Neoadjuvant drug therapy

## Key facts

- **NCT ID:** NCT06472752
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472752, "Neoadjuvant Radiotherapy for High-risk UTUC". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06472752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*